• Skip to main content
  • Skip to footer

PeDRA

Pediatric Dermatology Research Alliance

  • Pay 2021 Membership Dues
  • Our Membership
  • Login
MENUMENU
  • Contact
  • For Patients & Families
        • Patient Support
        • Patient Education
        • SPD's Find a Pediatric Dermatologist
        • Clinical Trials
        • Patient Advisory Committee
        • Learn more about PeDRA’s efforts to build capacity for patient engagement in pediatric dermatology research.

           

  • Education and Events
        • Virtual Education
        • PeDRA Podcasts
        • Mentorship Program
        • Early Career Support
        • 2021 PeDRA Annual Conference
        • Past PeDRA Conferences
        • Upcoming Events
        • Education and Events Archive
        • Save the Date!

          The 2021 PeDRA Annual Conference will take place October 14-16, 2021 in Bethesda, MD.

  • Research
        • Grants & Awards
        • Studies
        • Focused Study Groups
        • Publications
        • Clinical Trials
        •  

          Thanks to everyone who applied for a 2020 PeDRA Research Grant, Weston CDA, or Consensus Grant!

          2021 Research Fellowships will be our next open funding opportunity, with a deadline to apply of April 1, 2021.

  • About
        • Mission & Vision
        • Leadership & Staff
        • Annual Reports
        • News Archive
        • Our Supporters
        • Our Membership
        • Our Committees
        • Getting to Know You
        • PeDRA is an independent 501(c)(3) nonprofit organization driven by the mission to create, inspire, and sustain research to prevent, treat, and cure childhood skin disease.

  • Member Login

What does a pediatric BAP1 inactivated melanocytic tumor (BIMT) look like?

April 9, 2020 By Katherine Devenport

Principal Investigator:

Elena Hawryluk, MD, PhD
Massachusetts General Hospital

Overview:

Spitz nevi are a type of skin growth that occur most commonly in children. This study seeks to better understand Spitz nevi in children by determining possible overlap with a different entity known as BAP1 inactivated melanocytic tumors (BIMTs). BIMTs have many microscopic features that overlap with Spitz nevi, but are not well studied in children. Providers encountering BIMTs in children are not in agreement for the most appropriate management for these patients given the lack of data on these tumors.
We propose to study these tumors by performing special stains (BAP1, BRAF) on previously collected tissue for 30 identified cases of combined Spitz and dermal nevi. By better understanding these skin growths, we will be able to better assess if this subset of Spitz nevi should be re-characterized as BIMTs, and help shed light on the understanding and management of these poorlycharacterized skin growths in the pediatric population.

Status:

This project was funded by a 2019 PeDRA Research Grant.

Filed Under: Skin Tumors and Reactions to Cancer Therapies

Footer

  • Our Membership
  • For Patients
  • For Researchers
  • Forum
  • Facebook
  • Instagram
  • LinkedIn
  • Twitter
Sign up to receive emails from PeDRA
Join PeDRA
Donate

Copyright © 2021 · Pediatric Dermatology Research Alliance (PeDRA) · All Rights Reserved. · Privacy Policy